Benzil

Benzil

SCHEMBL2227748

Br.O=C(C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Benzil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 12/20 0.93
CES1 P23141 12/20 0.93
TSHR P16473 2/20 0.61
DAO P14920 1/20 0.61
NAPRT Q6XQN6 1/20 0.61
ALDH1A1 P00352 1/20 0.61
RAB9A P51151 1/20 0.58
CYP3A4 P08684 2/20 0.55
MAPT P10636 2/20 0.55
TDP1 Q9NUW8 2/20 0.55
CA2 P00918 2/20 0.55
CA4 P22748 2/20 0.55
POLB P06746 1/20 0.55
PARP1 P09874 1/20 0.55
CYP2C19 P33261 1/20 0.55
RECQL P46063 1/20 0.55
BLM P54132 1/20 0.55
PMP22 Q01453 1/20 0.55
HSD17B10 Q99714 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzil SCHEMBL28859327 1.00 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL2156589 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL66 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL28475956 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL9517636 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL7142843 0.97 CES2 (1.00) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL1002038 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL9799726 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL10996187 0.93 CES2 (0.93) CES2CES1TSHRDAONAPRT
Benzil SCHEMBL4957522 0.93 CES2 (1.00) CES2CES1TSHRDAONAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8465553-B2 Pigment dispersion composition, colored curable composition, color filter for solid-state image sensor and method of producing the same, and solid-state image sensor FUJIFILM CORPORATION (JP) 2013-06-18 US disclosed
EP-2524007-A1 PIGMENT DISPERSION COMPOSITION, COLORED CURABLE COMPOSITION, COLOR FILTER FOR SOLID-STATE IMAGE SENSOR AND METHOD OF PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR FUJIFILM Corporation (JP) 2012-11-21 EP disclosed
US-20120286145-A1 PIGMENT DISPERSION COMPOSITION, COLORED CURABLE COMPOSITION, COLOR FILTER FOR SOLID-STATE IMAGE SENSOR AND METHOD OF PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR FUJIFILM CORPORATION (JP) 2012-11-15 US disclosed
WO-2011087114-A1 PIGMENT DISPERSION COMPOSITION, COLORED CURABLE COMPOSITION, COLOR FILTER FOR SOLID-STATE IMAGE SENSOR AND METHOD OF PRODUCING THE SAME, AND SOLID-STATE IMAGE SENSOR FUJIFILM CORPORATION (JP) 2011-07-21 WO disclosed
US-20040059096-A1 Anti-ciguatoxin monoclonal antibody JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2004-03-25 US disclosed
EP-0855391-B1 NOVEL ISOQUINOLINE DERIVATIVES DAIICHI SEIYAKU CO (JP) 2003-10-15 EP disclosed
EP-1337333-A1 CATALYST SYSTEM FOR THE POLYMERIZATION OF OLEFINS Basell Polyolefine GmbH (DE) 2003-08-27 EP disclosed
US-20030017939-A1 Catalyst system for the polymerization of olefins OKUMURA YOSHIKUNI (DE) 2003-01-23 US disclosed
WO-2002038270-A1 CATALYST SYSTEM FOR THE POLYMERIZATION OF OLEFINS BASELL POLYOLEFINE GMBH (DE) 2002-05-16 WO disclosed
US-5959107-A Isoquinoline derivatives SNOW BRAND MILK PRODUCTS CO., LTD. (JP) 1999-09-28 US disclosed
EP-0855391-A1 NOVEL ISOQUINOLINE DERIVATIVES SNOW BRAND MILK PRODUCTS CO., LTD. (JP) 1998-07-29 EP disclosed
US-5468897-A Bi-aromatic esters, a process for their preparation and their use in human or veterinary medicine and in cosmetic compositions CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) 1995-11-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059096-A1 Anti-ciguatoxin monoclonal antibody PBK, IK, KLRK1 CES2 4412/4885CES1 3747/4885TSHR 1890/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.